Close

Genzyme Reports Top-line Results for TENERE Study of Oral Teriflunomide in Relapsing Multiple Sclerosis Dec 20, 2011 01:00AM
BioLineRx Reports Third Quarter 2011 Financial Results Nov 29, 2011 07:00AM
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis Nov 14, 2011 01:00AM
Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia Nov 10, 2011 01:00AM
Sanofi: Net sales up 10.1% and Business net income(1) up 4.1% at CER(2) Nov 3, 2011 07:30AM


Nov 3, 2011 03:05AM Sanofi Video Q&A: CFO Jérôme Contamine Comments on Q3 2011 Results
Oct 27, 2011 04:01PM ImmunoGen, Inc. Reports First Quarter Fiscal Year 2012 Financial Results and Provides Quarterly Update
Oct 27, 2011 07:00AM Regeneron Reports Third Quarter 2011 Financial and Operating Results
Oct 22, 2011 03:15AM Alemtuzumab (Lemtrada™*) Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study